Krystal Biotech to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
June 07 2022 - 7:00AM
Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in
redosable gene therapy, announced today that the Company will
participate in the Goldman Sachs 43rd Annual Global Healthcare
Conference in Rancho Palos Verdes, California.
Krish Krishnan, Chairman and Chief Executive Officer, will
represent the Company in a session scheduled at 10:40 am PDT on
Wednesday, June 15.
A live webcast of the presentation will be available here and on
the Investor section of the Company’s website.
About Krystal Biotech, Inc.Krystal Biotech,
Inc. (NASDAQ: KRYS) is a pivotal-stage gene therapy company
leveraging its proprietary, redosable gene therapy platform and
in-house manufacturing capabilities to develop life-changing
medicines for patients with serious diseases, including rare
diseases in skin, lung, and other areas. For more information
please visit http://www.krystalbio.com, and follow @KrystalBiotech
on LinkedIn and Twitter.
CONTACTS:Investors and
Media:Meg DodgeKrystal Biotechmdodge@krystalbio.com
Source: Krystal Biotech, Inc.
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Jul 2023 to Jul 2024